Prolonged PT
Publisher
Springer New York
Reference27 articles.
1. Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G. Antithrombotic therapy and prevention of thrombosis, 9th edition: American College of Chest Physicians evidence based clinical practice guidelines. Chest. 2012;141(2):e44S–88S.
2. Au N, Rettie AE. Pharmacogenomics of 4-hydroxycoumarin anticoagulants. Drug Metab Rev. 2008;40(355–375):2008.
3. Coyer DN, Millar DS, Wacey A, et al. Inherited factor VII deficiency, molecular genetics and pathophysiology. Thromb Haemost. 1997;78(1):151–60.
4. Dam H, Glavind J. Vitamin K in human pathology. Lancet. 1938;231:720–1.
5. D’Andrea G, D’Ambrosio RL, DiPerna P, et al. A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. Blood. 2005;105:645.